LIVING CELL TECHNOLOGIES LIMITED (LCT)
Living Cell Technologies: developing cell-based therapies for type 1 diabetes and neurological disorders.On this page you will find:
|
Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options |
|
Company details Closing prices Dividends Warrants & Structured Products ASX CFDs |
Delayed share price
Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.
| Code | Last | % Chg | Bid | Offer | Open | High | Low | Vol |
|---|---|---|---|---|---|---|---|---|
| LCT | 0.046 | -2.13% | 0.047 | 0.048 | 0.046 | 0.046 | 0.046 | 191,446 |
ASX Find a broker tool
Helps you find an ASX broker based on your needs and where you live.
LIVING CELL TECHNOLOGIES LIMITED details
Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.
| Issuer Code | LCT |
|---|---|
| Securities | |
| Official Listing Date | 1 September, 2004 |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences |
| Exempt Foreign? | No |
| Internet Address | http://www.lctglobal.com/ |
| Registered Office Address | Level 3, Suite 302, 70 Pitt Street, SYDNEY, NSW, AUSTRALIA, 2000 |
| Head Office Telephone | 1300 134 875 |
| Head Office Fax | (02) 9233 4497 |
| Share Registry | COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 5, 115 GRENFELL STREET, ADELAIDE, SA, AUSTRALIA, 5000 |
| Share Registry Telephone | 1300 787 272 |
| Directors / Senior Management |
|---|
|
Mr Roy Austin (Chairman, Independent Director) Ms Andrea Grant (Managing Director, CEO) Mr Robert Elliott (Executive Director) Mr Laurie Hunter (Independent Director) Mr Bernard Tuch (Independent Director) Mr Robert Moyse Willcocks (Independent Director) Mr John Cowan (CFO) |
| Company Secretary |
Mr Nick Geddes |
|---|---|
| Principal Activities | Living Cell Technologies: developing cell-based therapies for type 1 diabetes and neurological disorders. |
LIVING CELL TECHNOLOGIES LIMITED announcements
How are company announcements published on www.asx.com.au?
| Date | Price sens. |
Headline | Pages | |
|---|---|---|---|---|
| 09/05/2013 | Open Briefing LCT Clinical Trials Update | 4 | ||
| 29/04/2013 |
|
Appendix 4C - quarterly | 7 | |
| 21/03/2013 | CEO on Strategy - Audio Interview | 1 | ||
| 21/03/2013 | Open Briefing - CEO on Strategy | 5 | ||
| 20/03/2013 | Living Cell Technologies Awarded NZBIO Company of the Year | 2 | ||
| 27/02/2013 | Announcement on Half-Year Report | 2 | ||
| 27/02/2013 |
|
Appendix 4D and Half-Year Accounts | 21 | |
| 12/02/2013 | Change of Director's Interest Notice | 2 | ||
| 30/01/2013 |
|
Appendix 4C - quarterly | 7 | |
| 24/01/2013 | Change of Director's Interest Notice | 2 |
> search for past company announcements
Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.
Closing prices
Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.
| Date | Last | % Change | High | Low | Vol * |
|---|---|---|---|---|---|
| 24 May 2013 | 0.046 | -2.13% | 0.046 | 0.046 | 191,446 |
| 23 May 2013 | 0.047 | 0% | 0.047 | 0.047 | 55,000 |
| 22 May 2013 | 0.047 | -2.08% | 0.047 | 0.047 | 45,000 |
| 21 May 2013 | 0.048 | 0% | 0.048 | 0.046 | 300,000 |
| 20 May 2013 | 0.048 | 0% | 0.048 | 0.048 | 15,000 |
* Volume of shares shown represents only those shares traded on ASX.
LIVING CELL TECHNOLOGIES LIMITED price history chart

Dividends
How are dividends released on www.asx.com.au?
No dividends have been found for the security LCT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.
Exchange Traded Options
No Exchange Traded Options are available over the security LCT
Warrants & Structured Products
No warrants & Structured Products are available over the security LCT
ASX CFDs
No Contracts For Differences are available over the security LCT

